[1] 异基因造血干细胞移植临床输血专家共识起草专家组.异基因造血干细胞移植临床输血专家共识[J].临床输血与检验,2023,25(5):586-593. [2] DUNBAR N M,ORNSTEIN D L,DUMONT L J.ABO incompatible platelets:risks versus benefit[J].Curr Opin Hematol,2012,19(6):475-479. [3] KAUFMAN R M,DJULBEGOVIC B,GERNSHEIMER T,et al.Platelet transfusion:a clinical practice guideline from the AABB[J].Ann Intern Med,2015,162(3):205-213. [4] 孙国栋,尹志柱,刘景汉,等.特殊情况紧急抢救血小板ABO非同型输注回顾性分析[J].中国输血杂志,2016,29(4):345-347. [5] 叶星晨. ABO血型非同型血小板输注[J].国际输血及血液学杂志,2015,38(2):182-184. [6] QUILLEN K.Hemolysis from platelet transfusion:call to action for an underreported reaction[J].Transfusion,2012,52(10):2072-2074. [7] MALVIK N,LEON J,SCHLUETER A J,et al.ABO-incompatible platelets are associated with increased transfusion reaction rates[J].Transfusion,2020,60(2):285-293. [8] YıLDıZ A,DOĞAN M,YALVAÇ M,et al.Platelet inventory and using out-of-group platelet suspension:a cost-effective strategy for a blood transfusion service[J].Hematol Oncol Stem Cell Ther,2023,16(4):337-341. [9] PANDEY P,KUMARI S,MANDAL S,et al.A prospective observational study to compare transfusion outcomes in ABO identical versus ABO non-identical single donor platelet concentrates:an experience from a tertiary healthcare center in India[J].Transfus Clin Biol,2022,29(3):213-218. [10] 中国医师协会输血科医师分会,中华医学会临床输血学分会.特殊情况紧急抢救输血推荐方案[J].中国输血杂志,2014,27(1):1-3. [11] 上海市医学会输血专科分会,上海市临床输血质量控制中心.紧急抢救时ABO血型不相同血小板输注专家共识[J].中国输血杂志,2017,30(7):666-667. [12] ZIELINSKI M D,SCHRAGER J J,JOHNSON P,et al.Multicenter comparison of emergency release group A versus AB plasma in blunt-injured trauma patients[J].Clin Transl Sci,2015,8(1):43-47. [13] DUNBAR N M,YAZER M H,ON BEHALF OF THE BIOMEDICAL EXCELLENCE FOR SAFER TRANSFUSION COLLABORATIVE AND THE STAT STUDY INVESTIGATORS.Safety of the use of group A plasma in trauma:the STAT study[J].Transfusion,2017,57(8):1879-1884. [14] YAZER M H,SEHEULT J,KLEINMAN S,et al.Who's afraid of incompatible plasma? A balanced approach to the safe transfusion of blood products containing ABO-incompatible plasma[J].Transfusion,2018,58(2):532-538. [15] ZIELINSKI M D,JOHNSON P M,JENKINS D,et al.Emergency use of prethawed Group A plasma in trauma patients[J].J Trauma Acute Care Surg,2013,74(1):69-74;discussion 74-75. [16] CHHIBBER V,GREENE M,VAUTHRIN M,et al.Is group A thawed plasma suitable as the first option for emergency release transfusion? (CME)[J].Transfusion,2014,54(7):1751-1755;quiz 1750. [17] YAZER M,EDER A F,LAND K J.How we manage AB plasma inventory in the blood center and transfusion service[J].Transfusion,2013,53(8):1627-1633. [18] NOVAK D J,BAI Y,COOKE R K,et al.Making thawe d universal donor plasma available rapidly for massively bleeding trauma patients:experience from the Pragmatic,Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial[J].Transfusion,2015,55(6):1331-1339. [19] KAPLAN A,SEVCIK J,KISS J E.Low titer A plasma in three AB patients for therapeutic plasma exchange[J].J Clin Apher,2019,34(1):7-12. [20] KARAFIN M S,BLAGG L,TOBIAN A A R,et al.ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions[J].Transfusion,2012,52(10):2087-2093. [21] DANIEL-JOHNSON J,LEITMAN S,KLEIN H,et al.Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions[J].Transfusion,2009,49(9):1845-1849. [22] RUBY K N,HARM S K,DUNBAR N M.Risk of ABO-incompatible plasma from non-ABO-identical components[J]. Transfus Med Rev,2021,35(4):118-122. [23] 陈江,逯心敏,郭渝,等.羊水ABH血型物质测定与ABO血型基因分型[J].重庆医学,2014,43(11):1302-1303. [24] INABA S.Advancement in the preparation of red cell concentrates and platelet concentrates[J].Masui,2011,60(1):23-30. [25] MATHUR A,SWAMY N,THAPA S,et al.Adding to platelet safety and life:platelet additive solutions[J].Asian J Transfus Sci,2018,12(2):136-140. [26] REFAAI M A,FIALKOW L B,HEAL J M,et al.An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients[J].Vox Sang,2011,101(1):55-60. [27] ESTCOURT L J,STANWORTH S,DOREE C,et al.Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation[J].Cochrane Database Syst Rev,2014(3):CD010984. [28] 阳雪新,苑召虎,陈小洁,等.循环免疫复合物对血液病患者血小板输注疗效的影响[J].中国输血杂志,2022,35(4):404-408. [29] 林茹,王彦停,王辉亮,等.紧急抢救血小板ABO血型非同型输血的临床应用[J].中国输血杂志,2019,32(4):352-354. [30] TRIULZI D J,ASSMANN S F,STRAUSS R G,et al.The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia[J].Blood,2012,119(23):5553-5562. [31] JIMÉNEZ T M,PATEL S B,PINEDA A A,et al.Factors that influence platelet recovery after transfusion:resolving donor quality from ABO compatibility[J].Transfusion,2003,43(3):328-334. [32] BLUMBERG N,HEAL J M,HICKS G L Jr,et al.Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery[J].Transfusion,2001,41(6):790-793. [33] REFAAI M A,CARTER J,HENRICHS K F,et al.Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and-B[J].Transfusion,2013,53(2):382-393. |